The animal health company combines with its former owner in a reverse merger.
The worst appears to be over for this sector; we could see big growth ahead.
Both have good capital appreciation potential.
The oversold biotech sector is recovering.
©1996-2017 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.